Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 84.42 USD 1.14% Market Closed
Market Cap: 11.4B USD
Have any thoughts about
Globus Medical Inc?
Write Note

Globus Medical Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Globus Medical Inc
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Globus Medical Inc
NYSE:GMED
Net Change in Cash
$343.2m
CAGR 3-Years
46%
CAGR 5-Years
75%
CAGR 10-Years
18%
Becton Dickinson and Co
NYSE:BDX
Net Change in Cash
$375m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Net Change in Cash
$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Change in Cash
$2B
CAGR 3-Years
N/A
CAGR 5-Years
131%
CAGR 10-Years
23%
Abbott Laboratories
NYSE:ABT
Net Change in Cash
$849m
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
2%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Change in Cash
-$1.2B
CAGR 3-Years
-267%
CAGR 5-Years
-98%
CAGR 10-Years
-29%
No Stocks Found

Globus Medical Inc
Glance View

Market Cap
11.5B USD
Industry
Health Care
Economic Moat
None

Globus Medical Inc., founded in 2003, has crafted a distinctive narrative in the landscape of medical technology, rooted in innovation and practicality. Emerging from a profound understanding of spinal pathologies, the company has steadily risen to become a pivotal player in the musculoskeletal sector. Its journey is steered by a commitment to addressing complex spine disorders through the development of cutting-edge products that are not only innovative but also substantially user-friendly for both surgeons and patients. This fusion of technology and practicality is what sets Globus Medical apart. The company relentlessly focuses on expanding its product offerings through significant investments in research and development, continuously pushing the envelope in areas such as minimally invasive surgery, advanced surgical approaches, and imaging, which form the core of its business operations. The heart of Globus Medical's revenue model lies in its expansive product portfolio that serves surgeons and healthcare institutions globally. Their financial engine is powered by the sales of implants and related surgical instruments, meticulously designed to improve surgical outcomes. These products span a wide array of offerings including but not limited to advanced minimally invasive techniques and sophisticated trauma solutions. Beyond the traditional revenue streams, Globus Medical has ventured into promising areas like robotic surgery, thereby augmenting its revenue sources while accessing the benefits of technological advancements. This strategic direction not only strengthens its market position but also ensures it stays at the forefront of providing value-based solutions in the ever-evolving healthcare landscape. By integrating its technological prowess with a deep understanding of clinical needs, Globus Medical continues to carve a robust path for sustainable growth and leadership in the medtech sector.

GMED Intrinsic Value
82.29 USD
Overvaluation 3%
Intrinsic Value
Price

See Also

What is Globus Medical Inc's Net Change in Cash?
Net Change in Cash
343.2m USD

Based on the financial report for Sep 30, 2024, Globus Medical Inc's Net Change in Cash amounts to 343.2m USD.

What is Globus Medical Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
18%

Over the last year, the Net Change in Cash growth was 136%. The average annual Net Change in Cash growth rates for Globus Medical Inc have been 46% over the past three years , 75% over the past five years , and 18% over the past ten years .

Back to Top